Overview

Comparison of the Effects of Two Concentrations of Adrenaline (0.33 mg/l vs 1 mg/l) in the Irrigation Serum of Arthroscopic Shoulder Surgery

Status:
Recruiting
Trial end date:
2022-11-30
Target enrollment:
0
Participant gender:
All
Summary
The addition of adrenaline to the arthroscopic irrigation serum is used during rotator cuff surgery to limit intraoperative bleeding and ensure a clear view. Two concentrations of adrenaline are commonly used in practice: 1mg/L or 0.33 mg/L. The aim of this study is to determine which of these two doses provides better clarity of the surgical field with less impact on the patient's cardiovascular parameters.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
GCS Ramsay Santé pour l'Enseignement et la Recherche
Treatments:
Epinephrine
Epinephryl borate
Pharmaceutical Solutions
Racepinephrine
Criteria
Inclusion Criteria:

- Patient over 18 years of age, having read and signed the consent form for
participation in the study after a reflection period (approximately 15 minutes)

- Patient with a rotator cuff pathology (subacromial impingement, long biceps
tendinopathy or rotator cuff tendinopathy)

- Patient for whom an arthroscopic surgical indication has been given

Exclusion Criteria:

- Allergy to epinephrine

- History of Takotsubo cardiomyopathy

- Coagulation disorder

- Patient under court protection, guardianship or curatorship

- Patient not affiliated to the French social security system

- Patient participating in another therapeutic protocol

- Breastfeeding woman,

- Pregnant woman or woman of childbearing age without highly effective contraception for
the duration of the study (surgically sterile, intrauterine device (> 14 days),
hormonal contraception (same dose and formulation for at least 6 months), sexual
abstinence. Women of childbearing age, i.e. fertile, are considered to be
post-menopausal unless they are permanently infertile or have undergone surgical
sterilisation. A post-menopausal condition is defined as the absence of menstruation
for 12 months without any other medical cause

- Patient unable to understand informed information and/or give written informed
consent: dementia, psychosis, disturbed consciousness, non-French speaking patient